CSIMarket
 


Cure Pharmaceutical Holding Corp   (CURR)
Other Ticker:  
 

Cumulative Cure Pharmaceutical Holding 's Quick Ratio for Trailing Twelve Months Period

CURR's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CURR Quick Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2015)
II. Quarter
Y / Y Current Liabilities Growth 283975.47 % - - - -
Y / Y Cash & cash equivalent Growth 24722.62 % - - - -
Quick Ratio for Trailing Twelve Months Period 0.06 0.01 0.01 0 3.38
Total Ranking # 3756 # 5326 # 5387 # #
Seq. Current Liabilities Growth -42.79 % 5.02 % 3.29 % 457654.72 % -
Seq. Cash & cash equivalent Growth 8611.76 % -90.4 % 3218.75 % -10.61 % -


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Cure Pharmaceutical Holding Corp Cash & cash equivalent average more than doubled by 24722.62 % in III. Quarter year on year, faster than Current Liabilities, this led to increase in in Cure Pharmaceutical Holding 's Quick Ratio for Trailing Twelve Months Period to 0.06, Quick Ratio for Trailing Twelve Months Period remained below Cure Pharmaceutical Holding Corp average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 490 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Cure Pharmaceutical Holding . While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 3756, from total ranking in previous quarter at 5326.

What is Quick Ratio?
Learn more about CURR
Quick Ratio CURR in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 491
Sector # 1002
S&P 500 # 3745


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.06 0.02 0.01
(Sep 30 2022)   (Mar 31 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Ainos Inc   0.15 
Betterlife Pharma Inc.  0.15 
Orgenesis Inc   0.15 
Theralink Technologies Inc   0.13 
Neptune Wellness Solutions Inc   0.12 
Cardax Inc   0.11 
International Stem Cell Corporation  0.10 
Viatris Inc   0.08 
Axim Biotechnologies Inc   0.08 
Northwest Biotherapeutics inc  0.08 
Bioxytran Inc   0.08 
Cure Pharmaceutical Holding Corp   0.07 
Integrated Biopharma Inc  0.07 
Agex Therapeutics Inc   0.07 
Rebus Holdings Inc   0.06 
Vaccinogen Inc  0.06 
Cytodyn inc   0.06 
Veru Inc   0.05 
Immune Therapeutics Inc  0.04 
Musclepharm Corporation  0.04 
Landec Corporation  0.04 
Sunwin Stevia International Inc.  0.04 
Kaya Holdings Inc  0.04 
Bioadaptives Inc   0.03 
Nanomix Corporation  0.03 
American Bio Medica Corporation  0.03 
Regen Biopharma Inc   0.03 
Q Biomed inc   0.02 
Rapid Therapeutic Science Laboratories Inc   0.02 
Adhera Therapeutics Inc   0.02 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ESOA's Profile

Stock Price

ESOA's Financials

Business Description

Fundamentals

Charts & Quotes

ESOA's News

Suppliers

ESOA's Competitors

Customers & Markets

Economic Indicators

ESOA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071